Attovia Therapeutics, Inc.

US$15.27As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ATTOHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$697.1M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$17
10.19%
(65.52%)
Hold 10|9|3|2|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.38
0.36
0.39
0.39
26.09%
17.86%
17.74%
6.43%
Revenue$M
36.35
37.28
37.02
37.18
18.11%
17.43%
11.51%
5.82%
Peers (US$697.1M)
Cap (US$)
PE
689.7M
9.429x
Capital
TTM
5Y
10Y
Leveragex
1.303
(0.660)
(0.538)
EBIT/Intx
2.974
0.141
0.148
Own earn%
(20.41)
126.57
124.36
Sh yield%
48.00
35.12
34.75
Owners
Insiders/Inst%
9.77
45.55
Short interest%
2.01
SBC / revenue%
5.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
23–34
$1 testx
−0.1
Incr. ROIC%
1